NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation (NMTC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $31.8K.
Where they traded
Last open-market purchase: August 27, 2026 , by Wambeke David J. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Wambeke David J. | Chief Business Officer | Buy | 33,333 | $2.01 | $67.0K | 199,999 | |
| Christianson Mark | Market Development Director | Sell | 10,000 | $3.18 | $31.8K | 20,692 −32.6% of holding | |
| Christianson Mark | Business Development Director | Sell | 15,363 | $0.74 | $11.4K | 198,920 −7.2% of holding | |
| Christianson Mark | Business Development Director | Sell | 100 | $0.80 | $80 | 214,283 −0% of holding | |
| Christianson Mark | Business Development Director | Sell | 817 | $0.80 | $654 | 214,383 −0.4% of holding | |
| Christianson Mark | Business Development Director | Sell | 2,109 | $0.80 | $1.7K | 215,200 −1% of holding | |
| Christianson Mark | Business Development Director | Sell | 11,611 | $0.80 | $9.3K | 217,309 −5.1% of holding | |
| Wambeke David J. | Chief Business Officer | Buy | 1,000,000 | $0.67 | $670.4K | 1,000,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.